Victory: TX House Sends Safeguards Against Mail-Order Abortion Drugs to Abbott’s Desk

Contact: Prudence Robertson, [email protected] | 240-672-2828

Governor’s Priority Legislation One Step Closer to Becoming Law

Washington, D.C. – Today the Texas House of Representatives passed S.B. 4, legislation that guards against the expansion of dangerous mail-order chemical abortion drugs. One of Governor Greg Abbott’s short-list priorities for the special session, the bill passed the state Senate for the third time earlier this month and now heads to the governor’s desk.

The national pro-life group Susan B. Anthony List (SBA List) celebrated in a statement:

“The passage of vital safeguards on dangerous abortion drugs is a win for Texas women and unborn children,” said SBA List State Policy Director Sue Liebel. “Chemical abortion poses at least four times the risk of potentially serious complications compared to surgical abortion – yet pro-abortion Democrats in Washington are recklessly pushing for a permanent rollback of FDA safety standards that keep them from turning pharmacies and post offices into abortion centers. We thank Governor Abbott, pro-life leaders in the Texas House and Senate, and all our local allies who’ve prioritized this bill. It reflects the will of the people and we look forward to seeing the governor sign it swiftly into law.”

State Representative Stephanie Klick (TX-91), author of the bill and member of the National Pro-life Women’s Caucus, added:

“Safety protocols have existed since the Clinton administration at the federal level for women seeking to use abortion-inducing drugs, including an in-person visit with a doctor. As of April, the FDA is not enforcing this critical in-person doctor visit, which can help avoid serious complications or even death. This bill brings those safety protocols which have been effective for women for decades into Texas statute to ensure the doctor-patient relationship is intact and not at risk of being lost. This will save women’s lives.”

Chemical abortions constitute a growing percentage of U.S. abortions. A recent national study, written in part by scholars at the Charlotte Lozier Institute, examined cases of death and severe adverse events after chemical abortions nationwide, especially focusing on mifepristone, the first drug used in the two-part chemical abortion process.

The study analyzed complications which occurred between September 2000 and February 2019 in the U.S.:

  • More than 20 women died of complications from chemical abortions.
  • More than 500 life-threatening complications were reported.
  • Nearly 2,000 “severe” complications were reported.

The study authors also estimated that complications are significantly underreported in the U.S., with the U.S. Food and Drug Administration (FDA) relaxing reporting requirements even further in 2016.

SBA List is a network of 900,000 pro-life Americans nationwide, dedicated to ending abortion by electing national leaders and advocating for laws that save lives, with a special calling to promote pro-life women leaders.





Share this article: